DCM
AXSM icon

Driehaus Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Driehaus Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.2M Buy
372,474
+80,104
+27% +$17.4M 0.53% 57
2026
Q1 		$49.4M Buy
292,370
+71,852
+33% +$12.4M 0.36% 98
2025
Q4 		$40.3M Sell
220,518
-2,890
-1% -$403K 0.27% 123
2025
Q3 		$27.1M Buy
223,408
+128
+0.1% +$14.4K 0.19% 168
2025
Q2 		$23.3M Buy
223,280
+9,141
+4% +$968K 0.19% 161
2025
Q1 		$25M Buy
+214,139
New +$24.4M 0.24% 128
2024
Q2 		– Sell
-204,699
Closed -$16.3M – 371
2024
Q1 		$16.3M Sell
204,699
-61,143
-23% -$5.13M 0.16% 184
2023
Q4 		$21.2M Buy
265,842
+16,953
+7% +$1.13M 0.25% 127
2023
Q3 		$17.4M Buy
248,889
+117
+0% +$8.75K 0.23% 149
2023
Q2 		$17.9M Buy
248,772
+82,267
+49% +$6.07M 0.23% 143
2023
Q1 		$10.3M Sell
166,505
-66,590
-29% -$4.37M 0.14% 216
2022
Q4 		$18M Buy
+233,095
New +$13.9M 0.27% 127
2020
Q3 		– Sell
-241,284
Closed -$19.9M – 393
2020
Q2 		$19.9M Sell
241,284
-21,257
-8% -$1.64M 0.48% 60
2020
Q1 		$15.4M Sell
262,541
-13,176
-5% -$1.07M 0.52% 56
2019
Q4 		$28.5M Buy
+275,717
New +$11.1M 0.76% 26

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Driehaus Capital Management's AXSM Position: Q2 2026 in Review

Driehaus Capital Management increased its Axsome Therapeutics (AXSM) stake by 27% in Q2 2026, buying an estimated $17.4M and bringing the position to 372,474 shares worth $91.2M. The position accounts for 0.53% of the portfolio, ranked #57.

Driehaus Capital Management first reported a position in AXSM in Q4 2019 and has held it in 15 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Driehaus Capital Management held 372,474 shares of Axsome Therapeutics worth $91.2M as of Q2 2026.
  • Driehaus Capital Management bought 80,104 Axsome Therapeutics shares in Q2 2026, an estimated $17.4M.
  • Axsome Therapeutics made up 0.53% of Driehaus Capital Management's portfolio in Q2 2026, its #57 holding.
  • Driehaus Capital Management first reported a position in Axsome Therapeutics in Q4 2019 and has held it in 15 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.